Apollo Medical Stock Forecast, Price & News

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Apollo Medical in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" Apollo Medical stock.
View analyst ratings for Apollo Medical or view top-rated stocks.

2 analysts have issued 1 year price targets for Apollo Medical's shares. Their AMEH stock forecasts range from $75.00 to $92.00. On average, they anticipate Apollo Medical's stock price to reach $83.50 in the next year. This suggests a possible upside of 108.3% from the stock's current price.
View analysts' price targets for Apollo Medical or view top-rated stocks among Wall Street analysts.

Apollo Medical's stock was trading at $73.48 on January 1st, 2022. Since then, AMEH shares have decreased by 45.4% and is now trading at $40.09.
View the best growth stocks for 2022 here.

Apollo Medical is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for Apollo Medical.

Apollo Medical Holdings, Inc. (NASDAQ:AMEH) announced its earnings results on Thursday, May, 5th. The company reported $0.31 earnings per share (EPS) for the quarter. The company earned $263.26 million during the quarter. Apollo Medical had a net margin of 8.71% and a trailing twelve-month return on equity of 16.80%.
View Apollo Medical's earnings history.

Apollo Medical issued an update on its FY 2022 earnings guidance on Monday, May, 30th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.05 billion-$1.08 billion, compared to the consensus revenue estimate of $1.05 billion.

9 employees have rated Apollo Medical CEO Thomas Lam on Glassdoor.com. Thomas Lam has an approval rating of 43% among Apollo Medical's employees. This puts Thomas Lam in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Apollo Medical include Genpact (G), FTI Consulting (FCN), Exponent (EXPO), ICF International (ICFI), Huron Consulting Group (HURN), Montrose Environmental Group (MEG), The RMR Group (RMR), Cerberus Cyber Sentinel (CISO), The Hackett Group (HCKT), Tailwind Acquisition (TWND), Information Services Group (III), AgileThought (AGIL), BlackRock Capital Investment (BKCC), Atlas Technical Consultants (ATCX) and Mastech Digital (MHH).
View all of AMEH's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Apollo Medical investors own include PayPal (PYPL), SEA (SE), Mastercard (MA), NVIDIA (NVDA), Walt Disney (DIS), Lululemon Athletica (LULU), Enphase Energy (ENPH), Main Street Capital (MAIN), Square (SQ) and Exxon Mobil (XOM).

Apollo Medical trades on the NASDAQ under the ticker symbol "AMEH."

Apollo Medical's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (10.68%), Vanguard Group Inc. (7.00%), State Street Corp (2.18%), Northern Trust Corp (0.72%), Dimensional Fund Advisors LP (0.72%) and Bank of New York Mellon Corp (0.63%). Company insiders that own Apollo Medical stock include Adrian Vazquez, Albert Waichow Young, Brandon Sim, Eric Chin, Kenneth T Sim, Linda Marsh, Michael F Eng, Physicians Of Californi Allied and Thomas S Lam.
View institutional ownership trends for Apollo Medical.

AMEH stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., First Trust Advisors LP, Invesco Ltd., SG Americas Securities LLC, Northern Trust Corp, Bank of America Corp DE, Bank of New York Mellon Corp, and D.A. Davidson & CO.. Company insiders that have sold Apollo Medical company stock in the last two years include Adrian Vazquez, Albert Waichow Young, Linda Marsh, and Physicians Of Californi Allied.
View insider buying and selling activity for Apollo Medical or view top insider-selling stocks.

AMEH stock was bought by a variety of institutional investors in the last quarter, including Steel Peak Wealth Management LLC, Nordea Investment Management AB, State Street Corp, Graham Capital Management L.P., Vanguard Group Inc., BlackRock Inc., Dimensional Fund Advisors LP, and Bridgewater Associates LP. Company insiders that have bought Apollo Medical stock in the last two years include Brandon Sim, Physicians Of Californi Allied, and Thomas S Lam.
View insider buying and selling activity for Apollo Medical or or view top insider-buying stocks.

Shares of AMEH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AMEH stock can currently be purchased for approximately $40.09.

Apollo Medical (NASDAQ:AMEH) has a market capitalization of $2.25 billion and generates $773.91 million in revenue each year. The company earns $73.86 million in net income (profit) each year or $1.629990 on an earnings per share basis.

Apollo Medical employs 1,133 workers across the globe.

Apollo Medical's mailing address is 1668 S. GARFIELD AVENUE 2ND FLOOR, ALHAMBRA CA, 91801. The official website for Apollo Medical is www.apollomed.net. The company can be reached via phone at (626) 943-6491, via email at [email protected], or via fax at 818-839-5190.